The purpose of this study is to determine whether a novel standard of care protocol, washing red cell and platelet transfusions for younger patients with acute leukemia, has yielded improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This standard of care was implemented based upon an earlier randomized trial (BMC Blood Disorders. 2004 Dec 10;4(1):6) The comparator will be historical controls from the medical literature.
The purpose of this study is to determine whether a novel standard of care protocol, washing red cell and platelet transfusions for younger patients with acute leukemia, has yielded improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This standard of care was implemented based upon an earlier randomized trial (BMC Blood Disorders. 2004 Dec 10;4(1):6) The comparator will be historical controls from the medical literature. Key outcomes will be treatment related mortality (deaths at 30, 60 and 100 days) and three year survival.
Study Type
OBSERVATIONAL
Enrollment
100
Strong Memorial Hospital (University of Rochester Medical Center)
Rochester, New York, United States
Survial Rate at 30 Days
The percentage of patients who were alive at 30 days after transfusion.
Time frame: 30 days
Survial Rate at 60 Days
The percentage of patients who were alive at 60 days after transfusion.
Time frame: 60 days
Survial Rate at 100 Days
The percentage of patients who were alive at 100 days after transfusion.
Time frame: 100 days
Survial Rate at 5 Years
The percentage of patients who were alive at 5 years after transfusion.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.